IDEXX Laboratories Inc. (IDXX): Price and Financial Metrics


IDEXX Laboratories Inc. (IDXX): $395.79

10.87 (+2.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IDXX POWR Grades


  • IDXX scores best on the Quality dimension, with a Quality rank ahead of 95.47% of US stocks.
  • The strongest trend for IDXX is in Momentum, which has been heading down over the past 179 days.
  • IDXX's current lowest rank is in the Momentum metric (where it is better than 14.48% of US stocks).

IDXX Stock Summary

  • Idexx Laboratories Inc's market capitalization of $46,485,275,140 is ahead of 94.14% of US-listed equities.
  • The capital turnover (annual revenue relative to shareholder's equity) for IDXX is 4.66 -- better than 91.31% of US stocks.
  • The price/operating cash flow metric for Idexx Laboratories Inc is higher than 91.87% of stocks in our set with a positive cash flow.
  • Stocks that are quantitatively similar to IDXX, based on their financial statements, market capitalization, and price volatility, are BAX, ALC, CARR, FTV, and A.
  • Visit IDXX's SEC page to see the company's official filings. To visit the company's web site, go to www.idexx.com.

IDXX Valuation Summary

  • In comparison to the median Healthcare stock, IDXX's price/sales ratio is 65.64% higher, now standing at 18.8.
  • IDXX's price/sales ratio has moved up 16.7 over the prior 243 months.
  • IDXX's price/sales ratio has moved up 16.7 over the prior 243 months.

Below are key valuation metrics over time for IDXX.

Stock Date P/S P/B P/E EV/EBIT
IDXX 2021-08-31 18.8 76.7 78.8 67.2
IDXX 2021-08-30 19.2 78.2 80.3 68.5
IDXX 2021-08-27 18.7 76.1 78.1 66.7
IDXX 2021-08-26 18.8 76.6 78.7 67.2
IDXX 2021-08-25 18.9 77.0 79.1 67.5
IDXX 2021-08-24 18.8 76.5 78.6 67.1

IDXX Growth Metrics

    Its 5 year net cashflow from operations growth rate is now at 78.05%.
  • The year over year net income to common stockholders growth rate now stands at 54.33%.
  • Its 3 year cash and equivalents growth rate is now at -12.29%.
Over the past 52 months, IDXX's revenue has gone up $1,309,427,000.

The table below shows IDXX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 3,215.36 755.546 744.845
2021-09-30 3,135.208 764.516 756.864
2021-06-30 3,046.576 770.427 727.848
2021-03-31 2,858.026 744.614 674.206
2020-12-31 2,706.655 648.063 581.776
2020-09-30 2,591.163 584.542 497.482

IDXX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IDXX has a Quality Grade of A, ranking ahead of 96.19% of graded US stocks.
  • IDXX's asset turnover comes in at 1.342 -- ranking 14th of 680 Pharmaceutical Products stocks.
  • IMGN, RMTI, and MTEX are the stocks whose asset turnover ratios are most correlated with IDXX.

The table below shows IDXX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.342 0.588 0.424
2021-03-31 1.325 0.589 0.389
2020-12-31 1.322 0.580 0.344
2020-09-30 1.341 0.576 0.319
2020-06-30 1.332 0.572 0.314
2020-03-31 1.366 0.567 0.313

IDXX Price Target

For more insight on analysts targets of IDXX, see our IDXX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $717.50 Average Broker Recommendation 1.56 (Moderate Buy)

IDXX Stock Price Chart Interactive Chart >

Price chart for IDXX

IDXX Price/Volume Stats

Current price $395.79 52-week high $706.95
Prev. close $384.92 52-week low $330.66
Day low $388.49 Volume 139,093
Day high $397.61 Avg. volume 610,159
50-day MA $458.33 Dividend yield N/A
200-day MA $565.14 Market Cap 33.25B

IDEXX Laboratories Inc. (IDXX) Company Bio


IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 and headquartered in Westbrook, Maine, and EMEA in Hoofddorp, Netherlands, IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions (as of 7 February 2020). There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy (LPD). In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. (Source:Wikipedia)


IDXX Latest News Stream


Event/Time News Detail
Loading, please wait...

IDXX Latest Social Stream


Loading social stream, please wait...

View Full IDXX Social Stream

Latest IDXX News From Around the Web

Below are the latest news stories about Idexx Laboratories Inc that investors may wish to consider to help them evaluate IDXX as an investment opportunity.

How to Buy IDXX Stock Benzinga

Benzinga reviews IDEXX Laboratories and explains whether this stock is a buy given the recent upswing in the veterinary and companion animal industries.

Benzinga | February 23, 2022

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:

Yahoo | February 17, 2022

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.

Yahoo | February 17, 2022

10 ETFS To Buy During the Current Market Correction 

Like many U.S.-listed stocks, U.S.-listed ETFs have not gotten off to a great start in 2022.

Will Ashworth on InvestorPlace | February 10, 2022

2 Stocks With COVID Gains Wall Street Shouldn't Erase

Companies that benefited from the pandemic are in the financial news lately for all the wrong reasons. As businesses and consumers return to normal daily activities, some of the brands that became synonymous with stay-at-home orders and remote work have seen their stocks collapse.

Yahoo | February 9, 2022

Read More 'IDXX' Stories Here

IDXX Price Returns

1-mo -11.49%
3-mo -24.24%
6-mo -34.85%
1-year -28.56%
3-year 60.34%
5-year 136.21%
YTD -39.89%
2021 31.73%
2020 91.43%
2019 40.38%
2018 18.95%
2017 33.35%

Continue Researching IDXX

Here are a few links from around the web to help you further your research on Idexx Laboratories Inc's stock as an investment opportunity:

Idexx Laboratories Inc (IDXX) Stock Price | Nasdaq
Idexx Laboratories Inc (IDXX) Stock Quote, History and News - Yahoo Finance
Idexx Laboratories Inc (IDXX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6245 seconds.